Fundraising Fox
Congruence Therapeutics
Founded 2021 · 43 employees on LinkedIn · 8 known investors
Find your way into Congruence Therapeutics
Sign up to find every way you can get introduced to Congruence Therapeutics
- Your email: who you already know at Congruence Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Congruence Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.
Founders & leadership
Congruence Therapeutics was founded in 2021 by Clarissa Desjardins.
Investors · 8
How we know: OrbiMed's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: BDC Thrive Venture Fund for Women's portfolio page · Not right? Tell us
How we know: Lumira Ventures's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Related companies · 1
Companies working in the same space as Congruence Therapeutics.
Frequently asked questions
- What does Congruence Therapeutics do?
- Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.
- Who founded Congruence Therapeutics?
- Congruence Therapeutics was founded by Clarissa Desjardins in 2021.
- Who are Congruence Therapeutics's investors?
- Congruence Therapeutics's investors include OrbiMed, Alexandria, DIMENSION, Angelini Ventures, BDC Thrive Venture Fund for Women, Lumira Ventures, Amplitude Venture Capital, Dimension Capital.